suggested that smoker people with COX2 rs689466 polymorphism had a nearly 6-fold increased CRC risk compared with people without rs689466 risk allele (95% CI: 1.49–22.42, P  =  0.011) (35). This evidence concerns the gene PTGS2 and colorectal carcinoma.